MBX Biosciences, Inc.
MBX
DELAYED 1 MONTH

12 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 8, 2026May 11 8:01 PMSalomon AzoulayChief Medical Officer
Sale
70,003$38.36$2.7M14,769(D)

View →

May 6, 2026May 8 8:02 PMSalomon AzoulayChief Medical Officer
Sale
231$29.54$6.8K14,769(D)

View →

May 6, 2026May 8 8:00 PMHawryluk P. KentDirector, President & CEO
Sale
607$29.54$17.9K727,667(D)

View →

Mar 13, 2026Mar 16 12:02 PMHawryluk P. KentDirector, President & CEO
Purchase
18,500$28.41$525.7K486,777(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 5 6:35 PMEdward T MathersDirector
Grant/Award
12,500$30.9112,500(D)

View →

Jun 4, 2026Jun 5 11:59 AMOra H. PescovitzDirector
Grant/Award
12,500$30.9112,500(D)

View →

Jun 4, 2026Jun 5 11:59 AMPatrick J HeronDirector, 10% Owner
Grant/Award
12,500$30.9112,500(D)

View →

Jun 4, 2026Jun 5 11:58 AMLaurie StelzerDirector
Grant/Award
12,500$30.9112,500(D)

View →

Jun 4, 2026Jun 5 11:57 AMSteven L. HoerterDirector
Grant/Award
12,500$30.9112,500(D)

View →

Jun 4, 2026Jun 5 11:54 AMSteven RyderDirector
Grant/Award
12,500$30.9112,500(D)

View →

Jun 4, 2026Jun 5 11:53 AMTiba AynechiDirector
Grant/Award
12,500$30.9112,500(D)

View →

May 8, 2026May 11 8:01 PMSalomon AzoulayChief Medical Officer
Option Exercise
70,003$16.0030,008(D)

View →

May 1, 2026May 4 12:01 PMSteven L. HoerterDirector
Grant/Award
74,249$29.7874,249(D)

View →